First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

The present study investigated the survival benefit of non–anthracycline (ANT)-based vs ANT-based regimens in a large-scale, real-world cohort of patients with extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTCL). Within the China Lymphoma Collaborative Group (CLCG) database (2000-201...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Qi, Shu-Nan, Yang, Yong, Song, Yu-Qin, Wang, Ying, He, Xia, Hu, Chen, Zhang, Li-Ling, Wu, Gang, Qu, Bao-Lin, Qian, Li-Ting, Hou, Xiao-Rong, Zhang, Fu-Quan, Qiao, Xue-Ying, Wang, Hua, Li, Gao-Feng, Huang, Hui-Qiang, Zhang, Yu-Jing, Zhu, Yuan, Cao, Jian-Zhong, Wu, Jun-Xin, Wu, Tao, Zhu, Su-Yu, Shi, Mei, Xu, Li-Ming, Yuan, Zhi-Yong, Su, Hang, Zhu, Jun, Li, Ye-Xiong
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7362384/
https://ncbi.nlm.nih.gov/pubmed/32658985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001852
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados